Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,351
Total Claims
$739K
Drug Cost
1,337
Beneficiaries
$553
Cost/Patient
Risk Score Breakdown 37/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+541%
Opioid rate vs peers
58.9% vs 9.2% avg
-23%
Cost per patient vs peers
$553 vs $719 avg
-14%
Brand preference vs peers
5.7% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 541% above the average for Physician Assistant providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
58.9%
Opioid Rate
6,095
Opioid Claims
$411K
Opioid Cost
12.7%
Long-Acting Rate
This provider's opioid prescribing rate of 58.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 594 claims · $299K
Generic: 9,757 claims · $440K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Levorphanol Tartrate | 34 | $112K |
| Buprenorphine Hcl | 121 | $110K |
| Hydrocodone/Acetaminophen | 3,100 | $96K |
| Oxycodone Hcl/Acetaminophen | 864 | $60K |
| Oxycodone Hcl | 76 | $44K |
| Buprenorphine | 78 | $29K |
| Lidocaine | 181 | $26K |
| Diclofenac Sodium | 346 | $22K |
| Galcanezumab-Gnlm | 25 | $21K |
| Gabapentin | 890 | $16K |
| Gabapentin Enacarbil | 14 | $13K |
| Oxycodone Hcl | 574 | $13K |
| Tapentadol Hcl | 11 | $12K |
| Morphine Sulfate | 337 | $11K |
| Oxycodone Myristate | 20 | $9,033 |
Prescribing Profile
53
Unique Drugs
37.0
Anomaly Score
Patient Profile
68
Avg Age
59%
Female
2.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About